comparemela.com

Latest Breaking News On - Daniel geynisman - Page 2 : comparemela.com

Real-World Data Support Nivolumab + Ipilimumab for First-Line mRCC Therapy

Data from a real-world study support nivolumab + ipilimumab as first-line treatment for intermediate- or poor-risk mRCC.

United statesFrance generalFox chase cancer centerDaniel geynismanBristol myers squibbEuropean society for medical oncologyUs oncology networkEuropean societyMedical oncology

NCCN Announces Collaboration with Myovant Sciences and Pfizer to Support Projects to Understand and Mitigate Cardiovascular Risk in Patients with Prostate Cancer

/PRNewswire/ The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) today announced a collaboration with Pfizer and Myovant.

Balaji tamarappooDaniel geynismanFacebook nccnorgInstagram nccnorgZhaoping liCamille raginVivek narayanAlicia morgansDavid geffen school of medicineMyovant sciencesBren simon comprehensive cancer centerAbramson cancer centerOncology research programNational comprehensive cancer network oncology research programIndiana university melvinScientific review committee

Testicular Cancer Deaths Rising Among Hispanic Men

Testicular cancer–specific mortality rates in the United States have been increasing, particularly among Hispanic men and in certain geographic locations.

United statesMattd galskyAnushka ghoshDaniel geynismanCenters for disease control wideOnline data for epidemiologic researchTisch cancer institute at mount sinaiMassachusetts general hospitalGenitourinary cancers symposiumFox chase cancer centerNew findingsDisease controlWide ranging online dataEpidemiologic researchTisch cancer instituteMount sinai

Neoadjuvant Chemo New SOC Option in Urothelial Carcinoma

Neoadjuvant chemotherapy in the high-risk population demonstrated favorable pathologic responses, and was well tolerated.

United statesFox chaseSan franciscoDaniel geynismanCancers symposiumFox chase cancer centerMedscape medicalBladder cancerAlignant bladder neoplasmAlignant neoplasiaTransitional cell carcinomaDrug induced toxicityLymph node dissectionYmphatic obstruction

vimarsana © 2020. All Rights Reserved.